Clover Biopharmaceuticals
Clover is a biotechnology company that researches and develops transformative biologic therapies to treat oncology and autoimmune diseases.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Clover Biopharmaceuticals Information
Geographic Data
Address: No. 33, Jiaozi Streets
City: Chengdu
State: sichuan province
Zip: 610094
Country: CN
Financial Info
Stage:
post ipo equity
Raised Last:
$37M
Raised Total:$344M
Social
Metrics
4,371,855Website Global Rank
2,576Website Monthly Traffic
Twitter Followers
Description
Clover is a biotechnology company that researches and develops transformative biologic therapies to treat oncology and autoimmune diseases.
Contact Phone:
Contact Email:
Clover Biopharmaceuticals went public on 11/5/2021 on the Hong Kong Stock Exchange
Listed Exchange:
Hong Kong Stock Exchange
IPO Date:
11/5/2021
Ticker Symbol:
2197
IPO Price:
$1.7189216271944194/share
Amount Raised:
$240M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2017 | Series A | 1 | $9.5M |
Tianhe Life Sciences Venture Fund Tianhe Life Sciences Venture Fund |
6/2020 | Series B | 1 | $24M |
GL Ventures GL Ventures GL Ventures GL Ventures |
11/2021 | Post-IPO Equity | $36.9M | 11/2021 | Grant | $38.9M |
CEPI |
2/2021 | Series C | 5 | $230M |
Delos Capital GL Ventures Oceanpine Capital OrbiMed Temasek Holdings Delos Capital GL Ventures Oceanpine Capital OrbiMed Temasek Holdings |
11/2019 | Series B | 6 | $43.2M |
Beida Biomedical Industry Fund Lapam Capital Sichuan Province Healthy Pension Industry Equity Investment Fund Zhongguancun VC Development Center Delos Capital Lapam Capital Jinlong Group Beida Biomedical Industry Fund Lapam Capital Sichuan Province Healthy Pension Industry Equity Investment Fund Zhongguancun VC Development Center Delos Capital Lapam Capital |
11/2021 | IPO | $260.2M |
|
4/2020 | Equity | $3.5M |
Coalition for Epidemic Preparedness Innovations |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
